Ventmax SR (salbutamol sulphate) / Chiesi - LARVOL DELTA

Aerosol performance and sealing evaluation of new valved holding chamber face masks for babies and children (ERS 2023) - "Good sealing at small contact forces has the potential to improve inhalation therapy for babies and children. Further aerosol performance tests are planned.; General respiratory patient care; Public health; Pulmonary function testing; Cell and molecular biology; Epidemiology; Respiratory intensive care"

Clinical • Critical care • Infectious Disease • Pediatrics • Respiratory Diseases

Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network (ECFS 2023) - "Routine review of antibiotic efficacy and adherence monitoring is commonly done throughout the ECFS-CTN for pwCF with Pa infections. Consideration of non-Pa respiratory infections also influences regimen design."

Clinical • Cystic Fibrosis • Fibrosis • Genetic Disorders • Immunology • Infectious Disease • Pulmonary Disease • Respiratory Diseases

Advanced in-vitro test setup for valved holding chambers with pediatric facemasks (ERS 2022) - "Throat deposition of both active substances nebulized using VORTEX® + mask was reduced to 60% for pMDIs alone. Mask size does not influence the performance of the aerosol significantly."

Preclinical • Asthma • Immunology • Infectious Disease • Novel Coronavirus Disease • Pediatrics • Pulmonary Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections

Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. (PubMed, Lancet Respir Med) - P=N/A | "SAD is a complex and silent signature of asthma that is likely to be directly or indirectly captured by combinations of physiological tests, such as spirometry, body plethysmography, impulse oscillometry, and multiple breath nitrogen washout. SAD is present across patients with all severities of asthma, but it is particularly prevalent in severe disease. The clinical classification of SAD into two groups (a milder and a more severe group) by use of impulse oscillometry and spirometry, which are easy to use, is meaningful given its association with GINA severity stages, asthma control, quality of life, and exacerbations."

Biomarker • Clinical • Journal • Asthma • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases